Logo image of MURF

MURPHY CANYON ACQUISITION -A (MURF) Stock Fundamental Analysis

USA - NASDAQ:MURF - US6266421022 - Common Stock

16.85 USD
-0.14 (-0.82%)
Last: 9/22/2023, 8:14:36 PM
20 USD
+3.15 (+18.69%)
After Hours: 9/22/2023, 8:14:36 PM
Fundamental Rating

1

Taking everything into account, MURF scores 1 out of 10 in our fundamental rating. MURF was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of MURF have multiple concerns. MURF is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MURF had positive earnings in the past year.
MURF had a negative operating cash flow in the past year.
MURF Yearly Net Income VS EBIT VS OCF VS FCFMURF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 0 -500K -1M

1.2 Ratios

Industry RankSector Rank
ROA 3.22%
ROE 4.44%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MURF Yearly ROA, ROE, ROICMURF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 0 -5 -10 -15 -20

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for MURF so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MURF Yearly Profit, Operating, Gross MarginsMURF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, MURF has about the same amount of shares outstanding.
MURF has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MURF Yearly Shares OutstandingMURF Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 5M 10M 15M
MURF Yearly Total Debt VS Total AssetsMURF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 20M 40M 60M 80M 100M

2.2 Solvency

MURF has an Altman-Z score of 8.99. This indicates that MURF is financially healthy and has little risk of bankruptcy at the moment.
MURF has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 8.99
ROIC/WACCN/A
WACCN/A
MURF Yearly LT Debt VS Equity VS FCFMURF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 0.16 indicates that MURF may have some problems paying its short term obligations.
A Quick Ratio of 0.16 indicates that MURF may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.16
Quick Ratio 0.16
MURF Yearly Current Assets VS Current LiabilitesMURF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 200K 400K 600K

More info and screens

1

3. Growth

3.1 Past

MURF shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10152.00%, which is quite impressive.
EPS 1Y (TTM)10152%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%160%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

MURF is valuated quite expensively with a Price/Earnings ratio of 337.00.
The average S&P500 Price/Earnings ratio is at 27.42. MURF is valued rather expensively when compared to this.
Industry RankSector Rank
PE 337
Fwd PE N/A
MURF Price Earnings VS Forward Price EarningsMURF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MURF Per share dataMURF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MURF!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MURPHY CANYON ACQUISITION -A

NASDAQ:MURF (9/22/2023, 8:14:36 PM)

After market: 20 +3.15 (+18.69%)

16.85

-0.14 (-0.82%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.02%
Inst Owner Change-45.12%
Ins Owners21.94%
Ins Owner Change0%
Market Cap105.28M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 337
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 6.06
P/tB 6.06
EV/EBITDA N/A
EPS(TTM)0.05
EY0.3%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)-0.2
OCFYN/A
SpS0
BVpS2.78
TBVpS2.78
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.22%
ROE 4.44%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.16
Quick Ratio 0.16
Altman-Z 8.99
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10152%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%160%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-27358.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-21755.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-21755.2%
OCF growth 3YN/A
OCF growth 5YN/A